key: cord-0334057-7gzlslt5
authors: Solis, Gonzalo P.; Kazemzadeh, Arghavan; Valnohova, Jana; Abrami, Laurence; Alvarez, Cecilia; van der Goot, F. Gisou; Katanaev, Vladimir L.
title: Local and substrate-specific S-palmitoylation determines subcellular localization of Gαo
date: 2021-08-31
journal: bioRxiv
DOI: 10.1101/2020.08.25.266692
sha: f17daf301bb97aa2578e415926a9e078a4cd425f
doc_id: 334057
cord_uid: 7gzlslt5

Peripheral membrane proteins (PMPs) associate with cellular membranes through post-translational modifications like S-palmitoylation. The Golgi apparatus is generally viewed as the transitory station where palmitoyl acyltransferases (PATs) modify PMPs, which are then transported to their ultimate destinations such as plasma membrane (PM); little substrate specificity among the many PATs has been determined. Here we describe inherent partitioning of Gαo – α-subunit of heterotrimeric Go-proteins – to PM and Golgi, independent from Golgi-to-PM transport. A minimal code within the Gαo N-terminus governs the compartmentalization and re-coding produces G-protein versions with shifted localization. We established the S-palmitoylation at the outer nuclear membrane assay (“SwissKASH”) to probe substrate specificity of PATs in intact cells. With this assay, we showed that PATs localizing to different membrane compartments display remarkable substrate selectivity, which is the basis for specific PMP compartmentalization. Our findings uncover a novel mechanism governing protein localization and establish the basis for innovative drug discovery.

probe substrate specificity of PATs in intact cells. With this assay, we showed that PATs localizing to different membrane compartments display remarkable substrate selectivity, which is the basis for specific PMP compartmentalization. Our findings uncover a novel mechanism governing protein localization and establish the basis for innovative drug discovery.

G protein-coupled receptors (GPCRs) and their immediate transducers heterotrimeric G proteins have been the subject of intensive scrutiny for decades, primarily due to their pivotal roles in innumerable physiological and pathological processes 1 . Heterotrimeric G proteins are composed of Gα, Gβ and Gγ subunits. The Gα subunit is loaded with either GDP or GTP; the Gβ and Gγ subunits form a constitutive heterodimer that reversibly binds to Gα. GPCRs directly interact with heterotrimeric G proteins on the cytosolic surface of the membrane. Upon activation, GPCRs act as exchange factors to enhance the release of GDP from Gα, leading to the binding of GTP and activation of the Gα subunit. Subsequently, activated Gα dissociates from the receptor and the Gβγ heterodimer, and the free subunits are competent to interact with downstream targets 2 .

G protein activation via GPCRs has long been thought to occur exclusively at the plasma membrane (PM). Recently, however, considerable experimental evidence has accumulated supporting the notion that GPCRs can activate Gα subunits on the Golgi and other compartments 3 . Analogously, activation of the KDEL receptor (KDELR) by cargo from the endoplasmic reticulum (ER) was shown to trigger signal cascades via Gαs and Gαq/11, with KDELR acting as a non-canonical GPCR at the Golgi 4 . Our own work showed that KDELR also binds and activates monomeric Gαo, which in turn enhances the Golgi-to-PM trafficking via small Rab GTPases 5 . Therefore, the subcellular compartmentalization of Gα subunits appears to be of fundamental relevance for their functions. How Gα subunit compartmentalization is achieved and controlled, however, remains poorly understood.

Gα subunits are grouped into four subfamilies based on sequence and functional similarity:

Gαs, Gαq/11, Gα12/13 and Gαo/i 2 . All Gα subunits bind to membranes via fatty acid modifications at the N-terminus, i.e. N-myristoylation and S-palmitoylation 6 . While the majority of Gα subunits are single-palmitoylated, Gαo and other members of the Gαo/i subfamily are dual-lipidated. N-myristoylation occurs co-translationally and results in the attachment of a 14-carbon saturated fatty acid (myristate) to the N-terminal Gly via a stable amide bond 7 . S-palmitoylation occurs post-translationally and results in the attachment of a 16-carbon saturated fatty acid (palmitate) to a Cys residue through a reversible thioester linkage 8 . In vertebrates, N-myristoylation is catalyzed by two closely related Nmyristoyltransferases (NMT1 and NMT2) whose substrate specificities have been intensively studied in recent years 9 . Intracellular S-palmitoylation is catalyzed by a zinc-finger Asp-His-His-Cys domain-containing (zDHHC) family of palmitoyl acyltransferases (PATs) 10 . There are up to 24 zDHHCs described in mammals; opposite to NMTs, their substrate specificities are far from being well understood, although substantial advance has been made lately 11 .

Previously, S-palmitoylation of peripheral membrane proteins (PMPs), including Gα subunits, was shown to occur exclusively at the Golgi, with the palmitoylated proteins subsequently transported to the PM 12 . In recent years, however, cumulative data has emerged indicating that some PMPs might undergo local S-palmitoylation on their target compartments, namely the PM or ER 13, 14 . Experimental methods allowing visualization of S-palmitoylation in intact cells are highly demanded to properly address the issue of the site(s) of this crucial lipid modification.

Here, we define the critical parameters that govern Gαo N-myristolation, S-palmitoylation and subcellular compartmentalization. By engineering a system that allows the ectopic localization of zDHHCs to the outer nuclear membrane, we show an intriguing substrate specificity of several zDHHCs distinguishing among closely related substrates. Moreover, our data indicate that the steady-state localization of Gαo at the PM and Golgi apparatus is the outcome of local S-palmitoylation events. These findings contrast the previous view that i) Spalmitoylation of PMPs occurs exclusively at the Golgi and ii) serves to drive subsequent PM-directed delivery of such proteins. The unexpected selectivity among different PATs and their substrates we uncover to drive the intracellular localization of PMPs emerges as an attractive target for drug discovery.

Early studies using metabolic labeling with [ 3 

Gαo membrane association is mediated by N-myristoylation at Gly2 and S-palmitoylation at Cys3 in its N-terminus [15] [16] [17] . A recent structural analysis identified the recognition sequence of N-myristoyltransferases (NMTs) as an N-terminal hexapeptide, excluding Met1 18 Neuro-2a cells (N2a) and their localization at the plasma membrane (PM) and Golgi apparatus were compared with the full-length Gαo-GFP 5 . Surprisingly, Gαo-Nt 7 -GFP localized predominantly at the Golgi with weak PM localization remaining, whereas Gαo-Nt 31 -GFP displayed a more homogenous PM and Golgi distribution similar to Gαo-GFP ( Fig. 1bd) . Quantification of average fluorescence intensities at these compartments confirmed a much higher Golgi and a lower PM localization of Gαo-Nt 7 -GFP compared to Gαo-Nt 31 -GFP and Gαo-GFP (Fig. 1e,f) , despite similar expression level of the constructs ( Supplementary   Fig. 1g,h) . Then, we performed a crude subcellular fractionation of N2a cells expressing the constructs and showed that Gαo-Nt 7 -GFP, Gαo-Nt 31 -GFP and Gαo-GFP were similarly partitioned between the cytosolic and membrane fractions (Fig. 1g,h) . On the other hand, Gαo-Nt 8-31 -GFP was spread over the cytosol and nucleus ( Supplementary Fig. 1i ), indicating that the N-terminal α -helix alone is not sufficient for membrane association.

In the heterotrimeric G protein complex, the N-terminal α -helix of Gα is one of the regions binding to Gβ 19 . Since Gβ tightly interacts with Gγ, which in turn associates to membranes via its C-terminal prenylation 20 , we tested if the poor PM localization of Gαo-Nt 7 -GFP relates to a lack of Gβγ interaction. For this aim, we co-expressed the Gαo constructs together with mRFP-Gβ1 and mRFP-Gγ3 in N2a cells, and immunoprecipitated the GFP-fusions. Fulllength Gαo-GFP strongly pulled down Gβ1γ3, whereas Gαo-Nt 7 -GFP and Gαo-Nt 31 -GFP showed a very faint co-precipitation of Gβγ with no apparent difference between them ( Supplementary Fig. 1j) . Thus, the preferential localization of Gαo-Nt 7 -GFP to the Golgi, as opposed to the dual localization of Gαo-Nt 31 -GFP to Golgi and PM, is independent from Gβγ.

Together, these results indicate that Nt 7 is sufficient for Gαo overall membrane binding, but it tends to drive the Golgi rather than PM localization.

We next aimed to decode the rules of intracellular localization of Gαo-Nt 7 by a systematical point mutation analysis of its residues. Amino acid substitutions were designed using the GPS-Lipid prediction tool 21 . For instance, we introduced the Gly-to-Leu mutation at position 2 of Gαo-Nt 7 -GFP as GPS-Lipid predicted very high likelihood for S-palmitoylation at Cys3 in the mutant (not shown). However, the Gly2 mutation led to a complete loss of membrane association as Gαo-G2L-Nt 7 -GFP evenly spread over the cytosol and nucleus (Fig. 1i ). This result supports the notion that N-myristoylation is a prerequisite for S-palmitoylation in Gαo 6 .

Accordingly, Gαo-G2L-Nt 7 -GFP appeared almost exclusively in the cytosolic fraction ( Fig.   1k ,l). We then introduced the Cys-to-Asn mutation at position 3 as GPS-Lipid predicted a high score for N-myristoylation at Gly2 in the mutant (not shown). The resulting Gαo-C3N-Nt 7 -GFP was predominantly excluded from the nucleus and showed an ER-like distribution with certain accumulation at Golgi, which might account for the high membrane density of the cisternae stack (Fig. 1j) . Nevertheless, Gαo-C3N-Nt 7 -GFP appeared mostly in the cytosolic fraction (Fig. 1k,l) , confirming that N-myristoylation confers only weak membrane binding properties 7 . The distinct localization patterns of Gαo-Nt 7 mutants impaired in N-myristoylation and S-palmitoylation were not associated with significant variations in their expression levels ( Supplementary Fig. 1k ,l), and were emulated by the treatment with the specific inhibitors DDD85646 22 and 2-bromopalmitate (2-BrPal) 23 , respectively (Fig. 1m,n) . Defects in Spalmitoylation of Gαo-G2L-Nt 7 and Gαo-C3N-Nt 7 were confirmed by metabolic labeling with Supplementary Fig. 1m) , implying that the G2L and C3N GFP fusions were indeed S-palmitoylated. However, as the only Cys residues present in Gαo-C3N-Nt 7 -GFP lay within the GFP sequence, these results indicate that the remaining level of palmitoylation observed in these Nt 7 constructs originated from GFP -the observation frequent in the field.

The most recent substrate recognition motif for NMTs was described as

[KR] 7 , with ^ denoting exclusion of residues, and X -any amino acid 18 . The authors did not exclude the possibility that peptides lacking a positive charge at position 7 might also be accepted by NMTs. Thus, N-myristoylation of Gαo and all human N-myristoylated Gα subunits is not in conflict with the lack of a Lys/Arg residue at position 7 ( Supplementary Fig. 1a,d) . At position 6, a Ser residue is found in Gαo and its homologues, and Ser is by far the most frequent residue at this position among NMT substrates 18 . Thus, we first introduced point mutations at Ser6 in Gαo-Nt 7 based on the substrate recognition motif described by Castrec et al. and on a previous study indicating that Arg, Asn, Phe, and Val can occupy this position as well 24 . Substitution of Ser6 by Ala, Cys, Gly, or Thr showed efficient membrane binding (Fig. 1o ) and expression levels similar to Gαo-Nt 7 ( Supplementary Fig. 1n,o) . Interestingly, the S6C mutant displayed a strongly increased PM localization as compared to the wild-type Gαo-Nt 7 -GFP (Fig. 1o,q) and a migration shift in SDS-polyacrylamide gels ( Supplementary Fig. 1n ), suggesting that Cys3 and Cys6 both undergo S-palmitoylation and that PM targeting might be enhanced by the dual S-palmitoylation. N-myristoylation of these mutants was indirectly verified with the inhibitor DDD85646 (Fig. 1p) . Conversely, we observed a largely cytosolic and nuclear localization for the constructs in which the Ser6 was substituted by Arg, Asn, Phe and Val ( Supplementary Fig. 1p) , suggesting that such amino acid substitutions make the N-terminal peptide of Gαo a poor substrate for MNTs; the expression levels of the mutant constructs did not significantly differ from Gαo-Nt 7 -GFP ( Supplementary Fig. 1n ,o). We conclude that the lipid modifications and subcellular localization of the Gαo-Nt 7 constructs are highly sensitive to even minor changes in this heptapeptide sequence.

Intrigued by the S6C mutant, we questioned if the position of the Cys residue within Gαo-Nt 7 might play any role in its subcellular localization. Thus, we moved the Cys3 to positions 4 (MGNC-Nt 7 ) and 5 (MGNTC-Nt 7 ), and expressed the GFP constructs in N2a cells. An Asp residue was placed at position 3 following the GPS-Lipid prediction (not sown).

Unexpectedly, MGNC-Nt 7 -GFP displayed a completely different localization than its parental Gαo-Nt 7 (Figs. 1c, 2a), showing PM localization that was not only higher than that of Gαo-Nt 7 -GFP, but also of the full-length Gαo-GFP (Fig. 2c) . Moreover, the perinuclear structures labelled by MGNC-Nt 7 -GFP showed a much lower co-localization with the Golgi marker GM130 compared to Gαo-Nt 7 -GFP (Pearson's correlation; Figs. 1c, 2a,d). Instead, the perinuclear structures containing MGNC-Nt 7 -GFP co-localized better with Lactadherin-C2 (mRFP-Lact-C2; Supplementary Fig. 2a,b) , a biosensor for phosphatidylserine 25 . These results imply that MGNC-Nt 7 -GFP preferentially associates with the PM-derived endocytic rather than the Golgi-derived secretory pathway. The distinct localization of MGNC-Nt 7 -GFP was not the result of changed expression or membrane binding, as its level ( Supplementary  Fig. 1k ,l) and presence in the membrane fraction (Fig. 1k,l) were not significantly different from that of Gαo-Nt 7 -GFP. S-Palmitoylation of Cys4 in MGNC-Nt 7 -GFP was indirectly confirmed by sensitivity to the inhibitor 2-BrPal ( Supplementary Fig. 2c ). On the other hand, the Cys5 construct MGNTC-Nt 7 -GFP localized at the Golgi and cytosol (Fig. 2b ,d) but appeared mostly in the cytosolic fraction upon cell fractionation (Fig. 1k,l) . Thus, it appears that Cys5 is not a good substrate for palmitoyl acyltransferases (PATs), as MGNTC-Nt 7 -GFP closely resembles the C3N mutant (Fig. 1j,k,l) . Accordingly, metabolic labeling showed a wild-type-like [ 3 H]palmitate incorporation for MGNC-Nt 7 and only the residual signal for MGNTC-Nt 7 ( Supplementary Fig. 1m) . Intriguingly, the subcellular localization of MGNC-Nt 7 was fully recapitulated in the full-length Gαo when the same mutation was introduced.

Specifically, MGNC-Gαo-GFP showed a higher PM targeting (Figs. 1b, 2e,f) and a much lower co-localization with the Golgi marker GM130 (Figs. 1b, 2e,g) than Gαo-GFP despite comparable levels of expression ( Supplementary Fig. 2d ,e).

Altogether, these data uncover a remarkable characteristic of the N-terminal localization code of Gαo: minor changes in its amino acid sequence can drastically modify the subcellular localization of the protein. Due to its homology with all dual lipidated Gα subunits, and to other similarly modified PMPs, we reasoned that this principle might have a broad and evolutionary conserved relevance in biology.

We wanted to determine if Cys residues might exist at different positions within Nt 7 in eukaryotic Gα subunits. We searched for Gα sequences containing the N-myristoylation Table 2 ). Thus, we expressed a GFP-fusion of this sequence in N2a cells. Resultingly, MGSLCSR-Nt 7 -GFP showed stronger membrane binging than the initially designed MGNTC-Nt 7 -GFP localizing predominantly at Golgi with low cytosolic signal (cf. Fig. 2h and Fig. 2b ) despite similar expression level ( Supplementary   Fig. 1k ,l). When MGSLCSR was introduced into the full-length Gαo, however, the cytosolic localization of this mutant was well visible ( Supplementary Fig. 2f ), although its expression was comparable to Gαo-GFP ( Supplementary Fig. 2d Then, we expressed our constructs Gαo-Nt 7 -GFP, MGNC-Nt 7 -GFP and the consensus MGSLCSR-Nt 7 -GFP in the Drosophila Schneider-2 cell line. Remarkably, all constructs retained the same localization patterns as seen in N2a cells: Gαo-Nt 7 and MGSLCSR-Nt 7 targeted mainly Golgi stacks labelled by GalT-mRFP, while MGNC-Nt 7 associated largely with PM ( Fig. 2i-k) . Similar localizations were also seen in HeLa cells ( Supplementary Fig.   2g ). These data point to highly conserved rules for substrate compartmentalization across cell types and species.

Our next goal was to understand the molecular mechanism behind the contrasting subcellular localization of two rather similar sequences: Golgi for Gαo-Nt 7 and PM for MGNC-Nt 7 ( Fig. 1c and Fig. 2e ). N-myristoylation generally occurs during protein synthesis and confers a weak membrane binding to the modified protein 23 , and is essential for the subsequent S-palmitoylation to occur 6 . Our own data showed that myristoylated, but not palmitoylated Gαo-Nt 7 and MGNC-Nt 7 are indistinguishable in their localization and only prevented from free cytosolic and nuclear diffusion ( Fig. 1n and Supplementary Fig. 2c ).

Therefore, we speculated that S-palmitoylation is key for subcellular compartmentalization, by itself or in combination with the myristoyl group and/or neighboring amino acids. It has been suggested that S-palmitoylation of PMPs including Gα subunits occurs exclusively at the Golgi apparatus, the event followed by their transport to the PM via the secretory pathway 12 . In addition to the Golgi-to-PM trafficking, a proper steady-state localization of PMPs is controlled by their rapid and ubiquitous depalmitoylation 12 . Thus, we next explored whether the distinct localizations of Gαo-Nt 7 and MGNC-Nt 7 might involve a differential depalmitoylation and/or Golgi-to-PM transport of the constructs. Supplementary Fig. 2k ). This analysis supports the notion that the steady-state localization of PMPs results from a palmitoylation/depalmitoylation equilibrium 12 .

However, the fact that the PM content of Gαo-Nt 7 was not affected by Palmostatin B argues against a constant Golgi-to-PM flow of the construct.

We next aimed at visualizing how the Nt 7 constructs are trafficked in the cell. We adapted to our constructs the reverse dimerization (RD) assay, originally designed for the synchronized trafficking of secretory and integral membrane proteins 27 To further prove that PM localization of MGNC-Nt 7 -FM 4 -GFP is indeed independent from transport through Golgi, we performed the RD assay under the 20°C temperature block that forces cargos to accumulate in Golgi 28 . As control, we used the GFP-FM 4 -hGH construct that aggregates in the ER lumen and is secreted via the Golgi-mediated transport after chemical dissociation 29 . Incubation with D/D solubilizer for 45 min induced an almost complete secretion of GFP-FM 4 -hGH at 37°C, while at 20°C the construct strongly accumulated in Golgi (Fig. 3f) . Conversely, HeLa cells expressing MGNC-Nt 7 -FM 4 -GFP showed a comparable PM localization of the construct at both temperatures (Fig. 3g) . Quantification of MGNC-Nt 7 -FM 4 -GFP mean fluorescence intensity in the MannII-mRFP region revealed no significant difference in its Golgi content at 37°C and 20°C (Fig. 3h) , indicating that PM targeting of MGNC-Nt 7 does not occur via transport through Golgi.

Altogether, these results imply that the characteristic steady-state localizations of Gαo-Nt 7 and MGNC-Nt 7 are not related to the Golgi-to-PM trafficking. Instead, each of the constructs goes directly to its primary destination: Golgi or PM.

Thus far, our data indicate that S-palmitoylation might account for the compartmentalization of Gαo-Nt 7 and MGNC-Nt 7 , and that intracellular trafficking is not a major player in their distinctive localizations. We then envisioned two further scenarios that could explain the differential Nt 7 compartmentalization: (i) PATs have no specificity for substrate recognition, and the substrates concentrate at different compartments due to specific interactions, and (ii) PATs discriminate substrates, which in turn accumulate at the compartment where Spalmitoylation takes place. The first scenario involves a certain degree of promiscuity among PATs 11 , and implies that lipidations and a few surrounding amino acids confer specific binding properties e.g. to lipids, which are known to differentially accumulate all over the endomembrane system 30 . Additionally, fatty acids other than palmitate can also be attached to the available Cys and might confer different binding specificities to the S-acylated protein 31 . The second scenario requires that PATs discriminate between analogous substrates as small as Nt 7 and that a given substrate accumulates at the compartment where its specific PAT is localized.

To test the first scenario, we used membrane strips spotted with fifteen different lipids found in cellular membranes and performed a protein-lipid overlay assay 32 . As control, we employed a GFP-fusion of the pleckstrin homology (PH) domain of FAPP1 (FAPP1-PH-GFP), that specifically binds to phosphatidylinositol 4-phosphate (PI4P) 33 . N2a cells were transfected with Gαo-Nt 7 -GFP, MGNC-Nt 7 -GFP or FAPP1-PH-GFP, and then membrane strips were incubated with cleared cell extracts. As expected, FAPP1-PH-GFP showed a strong binding to the spot containing PI4P ( Supplementary Fig. 3a ). On the other hand, no apparent difference was found for Gαo-Nt 7 -GFP and MGNC-Nt 7 -GFP that mainly bound to phosphatidylserine, cardiolipin, and phosphoinositides, particularly to PI4,5P2

( Supplementary Fig. 3a) . A similar lipid-binding pattern was also observed by the larger construct Gαo-Nt 31 -GFP ( Supplementary Fig. 3a) . Thus, the compartmentalization of Gαo-Nt 7 and MGNC-Nt 7 is unlikely to emerge from different lipid-binding affinities, arguing against the first scenario.

Next, we studied the second scenario, which implies that local S-palmitoylation drives substrate compartmentalization. In mammals, intracellular S-palmitoylation is mediated by zDHHC proteins with PAT activity; 23 zDHHCs exist in humans and 24 in mice 10 . Most of the zDHHCs have four transmembrane domains (TMDs), whereas only two and three members present five and six TMDs, respectively 11 . The majority of zDHHCs localize at Golgi and the remaining are distributed among the ER, PM and endosomes 34, 35 . In order to confirm their subcellular localization, we expressed a collection of twenty-three HA-tagged mouse zDHHCs in N2a cells 36 . As expected, immunostainings revealed that a large number of zDHHCs localized predominantly at Golgi: zDHHC3, 7, 9, 12, 13, 15-17, 21, 23, and 25 ( Supplementary Fig. 3b ). Six showed a clear PM localization but were also found on endosomes: zDHHC2, 5, 11, 14, 18, and to a lesser extent zDHHC8. The rest of the PATs mostly showed ER localization, while zDHHC4 associated almost exclusively with the nuclear envelope ( Supplementary Fig. 3b ), a pattern not described in previous studies 34, 35 .

Beside a unique antibody that specifically recognizes palmitoylated PSD-95 37 , experimental approaches to study zDHHC-substrate pair relations are based exclusively on disruptive biochemical and proteomic techniques 38 . To determine if Gαo-Nt 7 and MGNC-Nt 7 are differently lipidated at PM vs. Golgi, we aimed at developing a method to visualize local Spalmitoylation in intact cells. Inspired by the nuclear envelope localization of zDHHC4, we engineered zDHHCs that ectopically target the outer nuclear membrane (ONM) to detect mislocalized substrates. We took advantage of some components of the well-studied LINC family, which in turn are inserted in the inner nuclear membrane 39 . As C-termini of all zDHHCs except zDHHC24 face the cytosol, we hypothesized that addition of a C-terminal KASH-domain might induce their targeting to the ONM (Fig. 4a ). To test this hypothesis, we first generated a zDHHC5 construct carrying N-terminal mRFP for visualization and the KASH-domain of syne-1/nesprin-1 at its C-terminus (mRFP-zDHHC5-KASH). In HeLa cells, the KASH-domain alone (mRFP-KASH) is efficiently targeted to the ONM (Fig. 4b) , and mRFP-zDHHC5 localized at PM and endosomes as expected ( Fig. 4c and Supplementary   Fig. 3b) . Addition of the KASH domain strongly impaired PM localization of zDHHC5 ( Fig.   4d ), but a robust ONM targeting was only achieved by the co-expression of the KASHinteracting protein SUN2 (Fig. 4e ).

Next, we analyzed if known zDHHC-substrate pair relations can be recapitulated in HeLa cells and chose the PMPs SNAP23, caveolin-1 and flotillin-2. The core of SNAP23 contains 6

Cys residues that are palmitoylated by zDHHC13 and 17 40 . zDHHC7 appears as the main PAT for caveolin-1, which is palmitoylated in 3 Cys residues at its C-terminus 41 flotillin-2 ( Supplementary Fig. 4c ) were efficiently recruited to the ONM by the corresponding zDHHC-KASH constructs. Together, we successfully developed a system in intact cells for the visualization of local S-palmitoylation at the ONM and named it the "SwissKASH" assay.

Once the SwissKASH assay was established, we first tested if PM-associated zDHHCs showed differential substrate specificities for Gαo-Nt 7 and MGNC-Nt 7 . In addition to zDHHC5, were efficiently recruited to the ONM by co-expression of mRFP-zDHHC11-KASH but not by the control mRFP-KASH ( Fig. 5a-d) . To quantify these effects, we measured the mean GFP-fluorescence intensity at the ONM and nearby cytosol, and used their ratio to determine the relative ONM content of the Nt 7 constructs. Quantification revealed a similar ~2.5-fold accumulation of Gαo-Nt 7 -GFP and MGNC-Nt 7 -GFP at the ONM by co-expression of mRFP-zDHHC11-KASH (Fig. 5e ), suggesting that zDHHC11 equally accepts both Nt 7 constructs as substrate. On the other hand, the KASH-fusions of zDHHC2, 5, 8, 14 and 18 showed no effect on the localization of Gαo-Nt 7 -GFP and MGNC-Nt 7 -GFP in HeLa cells ( Supplementary   Fig. 4d ,e). Thus, it appears that the predominant PM localization of MGNC-Nt 7 cannot be explained by major differences in substrate specificity of PM-associated zDHHCs. Our data also identifies zDHHC11 as the main PM-localized PAT for Gαo.

Next, we applied the SwissKASH system to Gαo-Nt 7 and MGNC-Nt 7 using the eleven Golgi- Fig. 5b ). Quantification showed that Gαo-Nt 7 -GFP accumulates at the ONM roughly 2.0 and 2.5 folds by the co-expression of zDHHC3 and zDHHC7, respectively (Fig. 5j,k) . Conversely, MGNC-Nt 7 -GFP presented a significantly lower ONM recruitment of ~1.5 folds by zDHHC3 and 7 (Fig. 5j,k) .

As the KASH-fusion of zDHHC11 was able to target both Gαo-Nt 7 and MGNC-Nt 7 to the ONM (Fig. 5b,d,e) , we asked whether it acts in an indiscriminative manner or can still distinguish among different Nt 7 substrates. Answering this question, we found that mRFP-zDHHC11-KASH induced strong ONM recruitment of MGSSCSR-Nt 7 -GFP but showed a much weaker effect on MGLLCSR-Nt 7 -GFP ( Supplementary Fig. 6a-c) , both sequences commonly found in plant Gα subunits (Supplementary Notes and Supplementary Table 1) .

Thus, we conclude that zDHHC3, 7 and 11 all can differentiate among Nt 7 substrates with even slight variations in the amino acid composition.

S-palmitoylation of Nt 7 at the ONM: role of enzymatic PAT activity and accessory proteins The data above speak for the unexpected specificity of different zDHHCs to Nt 7 substrates that results in specific substrate localizations. We wondered whether these effects could simply result from physical interactions, differential among different zDHHC-substrate pairs. However, we identified that the zDHHCs do not possess high-affinity binding abilities to the Nt 7 sequences, as immunoprecipitation of Gαo-Nt 7 -GFP, MGNC-Nt 7 -GFP, MGSSCSR-Nt 7 -GFP or MGLLCSR-Nt 7 -GFP did not co-precipitate any of the three tested mRFP-zDHHC11/3/7-KASH constructs ( Supplementary Fig. 4f, Supplementary Fig. 5c ,d, Supplementary Fig. 6d) . Thus, the effects we uncovered are more consistent with specific yet transient, enzymatic interactions among PATs and different substrates.

To confirm that the enzymatic PAT activity was indeed necessary for the selective mislocalization of substrates in the SwissKASH assay, we generated zDHHC-inactive constructs by a Cys-to-Ser mutation in the catalytic DHHC domain 36 . Indeed, the ability of the KASH-fusions of zDHHC3, 7 and 11 to induce ONM accumulation of Gαo-Nt 7 and MGNC-Nt 7 was completely abolished when the DHHS-mutants were co-expressed instead of the wildtype PATs (Fig. 5l-o) .

In recent years, a few accessory proteins have been implicated in regulation of several zDHHCs 43 . Here, we focused on two closely related PMPs: GCP16/Golga7 that has been reported to interact with the PM-localized zDHHC5 44 as well as the Golgi-localized zDHHC9 45 , and Golga7b which associates with zDHHC5 only 46 . We added a Flag-tagged GCP16/Golga7 construct to the SwissKASH system for zDHHC5 and 9, and applied it to Gαo-Nt 7 and MGNC-Nt 7 . Interestingly, GCP16/Golga7 was strongly recruited to the ONM by the KASH-fusion construct of zDHHC5 but not zDHHC9 ( Supplementary Fig. 7a-d) . This effect was not seen when the DHHS-mutant of zDHHC5 was used, suggesting that GCP16/Golga7 is a substrate for zDHHC5 ( Supplementary Fig. 7e-g) . On the other hand, Gαo-Nt 7 -GFP and MGNC-Nt 7 -GFP were not targeted to the ONM in the SwissKASH system using GCP16/Golga7 together with zDHHC5 or 9 ( Supplementary Fig. 7a-d) .

We then tested a Flag-tagged Golga7b construct in the SwissKASH assay for zDHHC5 and also observed its accumulation at the ONM (Fig. 6a,b) . Surprisingly, we also observed ONM recruitment of MGNC-Nt 7 -GFP but not Gαo-Nt 7 -GFP under these conditions (Fig. 6a,b) ; both Golga7b and MGNC-Nt 7 were not targeted to the ONM when the DHHS-mutant of zDHHC5 was used (Fig. 6c) . We were not able to detect any ONM localization of MGNC-Nt 7 without the co-expression of Golga7b ( Supplementary Fig. 4e) , implying that the zDHHC5-Golga7b complex might be involved in substrate recognition similar to zDHHC9-GCP16/Golga7 45 .

Quantification showed a significant ONM accumulation of MGNC-Nt 7 -GFP over Gαo-Nt 7 -GFP and control (Fig. 6d) , which is not due to a differential protein-interaction with mRFP-zDHHC5-KASH, as both Nt 7 constructs did not co-precipitate the PAT (Supplementary Fig.   7h ).

Then, we asked whether the higher PM targeting of Gαo-Nt 31 compared to Gαo-Nt 7 might also be the outcome of different zDHHC substrate specificities. Thus, we tested if zDHHC3, 7, and 11 target Gαo-Nt 31 to the ONM with the same efficiency than Gαo-Nt 7 . Although zDHHC11-KASH efficiently relocalized Gαo-Nt 31 -GFP to the ONM, zDHHC3 and zDHHC7 showed a weaker effect when compared to Gαo-Nt 7 -GFP ( Fig. 6e-i) . Additionally, we did not observe ONM targeting of Gαo-Nt 31 -GFP by the co-expression of mRFP-zDHHC5-KASH and Golga7b ( Supplementary Fig. 7i) . Therefore, the weaker activity of the Golgi zDHHC3 and 7 toward Gαo-Nt 31 predicts an increase in its PM accumulation upon time, in agreement with the experimental findings (Fig. 1d) .

Together, our data suggest that the distinct steady-state localizations of Gαo-Nt 7 and MGNC-Nt 7 are due to the differential substrate specificities of PM-and Golgi-localized enzymatically active zDHHCs, which can further be differently influenced by the accessory proteins.

The notion that compartmentalization is controlled by PATs implies that the localization of Nt 7 constructs might be shifted toward the PM or Golgi by manipulating the expression level of specific zDHHCs. To test this hypothesis, we first co-transfected N2a cells with Gαo-Nt 7 -GFP and HA-zDHHC11, and determined its relative PM content and co-localization with the MannII-BFP Golgi marker. Additionally, we co-expressed MGNC-Nt 7 -GFP together with HA-zDHHC3 or HA-zDHHC7. Remarkably, the PM localization of Gαo-Nt 7 strongly increased by the overexpression of zDHHC11, whereas its co-localization with MannII-BFP showed a significant decrease (Fig. 7a-d) . On the other hand, MGNC-Nt 7 presented a higher colocalization with the Golgi marker but a significant decrease in PM content by the co- Fig. 8g-i) . Similarly, co-expression of zDHHC5 and Golga7b appeared not to alter the localization pattern of the Nt 7 constructs ( Supplementary Fig. 8j,k) .

Next, we analyzed the localization of Gαo-Nt 7 and MGNC-Nt 7 in cells after depletion of zDHHCs. We employed HeLa instead of the murine N2a cells for this analysis, as siRNAs have been used successfully to downregulate the expression of human zDHHCs in this cell line 47 . We first determined if, in addition to zDHHC5 (Fig. 4c) , zDHHC3, 7 and 11 show localizations in HeLa similar to those in N2a cells ( Supplementary Fig. 3b) . Accordingly, HA-tagged zDHHC3 and 7 were predominantly localized at the Golgi, while zDHHC11 was at the PM ( Supplementary Fig. 9a-c) . Since only minor effects were observed by single siRNA transfections (data not shown), we expressed Gαo-Nt 7 -GFP or MGNC-Nt 7 -GFP in cells pretreated with siRNAs against the pairs of zDHHC3/7 and zDHHC5/11. Gαo-Nt 7 and MGNC-Nt 7 localized normally in HeLa cells transfected with control siRNA, with Gαo-Nt 7 predominantly at the Golgi and MGNC-Nt 7 mainly at the PM (Fig. 8a,d) . Remarkably, the simultaneous depletion of the Golgi-associated zDHHC3 and 7 clearly affected the localization of Gαo-Nt 7 : the construct exhibited a much weaker presence at the Golgi whereas its targeting to the PM appeared enhanced (Fig. 8b) . MGNC-Nt 7 , however, was not affected by this treatment (Fig. 8e ), but its localization was notoriously shifted toward the Golgi in HeLa cells upon the concomitant downregulation of the PM-associated zDHHC5 and 11 (Fig. 8f) . On the other hand, distribution of the Gαo-Nt 7 construct did not show major changes in cells depleted of zDHHC5 and 11 (Fig. 8c ). Quantification showed a significant reduction in the relative Golgi localization of Gαo-Nt 7 by the downregulation of zDHHC3/7, and a significantly increase in the Golgi content of MGNC-Nt 7 upon zDHHC5/11 depletion (Fig. 8g) .

Collectively, these data confirm the conclusion that local S-palmitoylation plays a pivotal role in the compartmentalization of Gαo-Nt 7 and MGNC-Nt 7 , and that the localization pattern can be shifted upon up-or down-regulations of different PATs.

We analyzed next if the SwissKASH assay might reveal local S-palmitoylation of the fulllength Gαo. Thus, we expressed Gαo-GFP together with the KASH-fusions of zDHHC3, 7, and 11, as they showed activity toward Gαo-Nt 7 in N2a cells. Remarkably, full-length Gαo-GFP was targeted to the ONM by these zDHHC constructs (Fig. 9a-d) . Alternatively, the Cys4 mutant of Gαo, MGNC-Gαo-GFP, localized at the ONM primarily when the KASHfusion for zDHHC11 was co-expressed ( Supplementary Fig. 9d) , similar to what we observed 1 for MGNC-Nt 7 -GFP (Fig. 5d,h,i) . MGNC-Gαo-GFP was additionally targeted to the ONM by co-expression of mRFP-zDHHC5-KASH and Golga7b, an effect not seen for Gαo-GFP (Fig.   9e,f) . Overall, our data confirm that the distinct steady-state localization of Gαo is controlled by the PM-and Golgi-localized zDHHCs.

To explore a potential role of ER-resident PATs in Gαo localization, we co-expressed Gαo-GFP with the HA-tagged zDHHC1, 4, 6, 19, 20 and 24 in HeLa cells, but observed no apparent effect in Gαo distribution (Supplementary Fig. 9e ). We noticed that zDHHC1 and to a lesser extend zDHHC20 were also present at the PM in HeLa cells ( Supplementary Fig.   9e ), a pattern that was not obvious in N2a cells ( Supplementary Fig. 3b ). Thus, we generated mRFP-KASH fusions for these PATs and tested their ability to target Gαo-Nt 7 and MGNC-Nt 7 to the ONM in the SwissKASH assay. The KASH-fusion efficiently targeted zDHHC1 and 20

to the ONM, but they were not able to recruitment Gαo-Nt 7 or MGNC-Nt 7 ( Supplementary   Fig. 10a-d) .

Finally, we wondered whether the pool of Gαo targeting the ONM would keep its functionality. To address this, we first tested the ability of Gαo to interact with Gβ1γ3. As expected, Gαo-GFP and mRFP-Gβ1γ3 strongly co-localized at the PM and endomembranes in control HeLa cells (Supplementary Fig. 10e ). When these components of the G protein heterotrimer were expressed together with zDHHC11 in the SwissKASH assay, mRFP-Gβ1γ3 relocalized to the ONM in the pattern identical to Gαo-GFP (Fig. 9g) . We tested next if a downstream signaling molecule might be co-recruited to the ONM by Gαo, and selected RGS19 which preferentially interacts with the active, GTP-loaded Gαo 48 . In addition to Gαo-GFP wild-type, we used the GTPase-deficient mutant of Gαo (Q205L) that is present in the GTP-loaded state in cells. Accordingly, a clear ONM accumulation of a His 6 -tagged RGS19 construct was observed when the SwissKASH system was applied to the Q205L mutant ( Fig.   9h ) but not the wild-type Gαo (Supplementary Fig. 10f) . Altogether, our SwissKASH system shows that local S-palmitoylation of Gαo can cause its in-situ accumulation in the signalingcompetent form, indicating that zDHHC selectivity and subcellular localization are key players in the substrate compartmentalization of the G protein, and potentially PMPs in general.

That Gα subunits can be found at the Golgi apparatus is known for 30 years 49 . The Golgi localization of Gα subunits was assumed to be part of their trafficking pathway to the cell periphery, although some non-canonical functions of G-proteins were described at compartments other than the PM 50 . Only recently, the Golgi-pool of Gα subunits has been implicated in the downstream signaling of typical GPCRs 3 and the KDEL receptor 4, 5 . Thus, subcellular compartmentalization has emerged as an important player in G protein functions.

The present study provides an in-depth characterization of key elements controlling Nmyristoylation, S-palmitoylation and localization of Gαo. More importantly, we developed a system SwissKASH for the rapid detection of zDHHC-substrate pair relations in intact cells, opposing to the disruptive biochemical and proteomic techniques currently used to study S-palmitoylation 38 . Altogether, this work supports a model in which local Spalmitoylation by distinct zDHHCs is crucial for Gαo compartmentalization, and most likely for other PMPs (Fig. 10 ). In this model, N-myristoylation allows the nascent protein to reach virtually the whole endomembrane system. Subsequently, specific PM-and Golgi-localized zDHHCs catalyze S-palmitoylation of PMPs, which in turn accumulate at these compartments. Our model is in agreement with the local S-palmitoylation described for substrates such as PSD-95 at dendritic spines 37 and calnexin at the ER 47 , but adds the Golgi as a compartment in which PMPs can be locally modified and retained. To our knowledge, Spalmitoylation via the large number of Golgi-localized zDHHCs has been exclusively discussed in the context of Golgi-to-PM transport of integral 52 and PMPs 12 . We hereby challenge this notion and show instead that PMP localization to one compartment or another (including Golgi and PM) is not a consequence of sequential trafficking of the PMPs but rather a direct localization driven by the substrate-specific PAT activities at different compartments.

The fact that zDHHCs can modify multiple substrates has led to the notion that Spalmitoylation is nonspecific and proximity-based. Accordingly, a recent study demonstrated the stochastic S-palmitoylation of engineered Cys residues in membrane proteins, proposing that catalysis is determined by substrate accessibility and not specific sequence motifs 53 .

Several zDHHCs, however, contain PDZ-binding motifs, SH3 domains or ankyrin-repeats outside the catalytic DHHC core that have been implicated in enzyme-substrate interactions 11 . Importantly, our study uncovered a striking substrate specificity for several zDHHCs toward peptides as small as Gαo-Nt 7 . We additionally showed that minor sequence modifications might result not only in drastic changes in the substrate recognition by zDHHCs, but also in substrate localization (Fig. 10) . Another interesting implication of this model is that cells and tissues could shift the localization and associated function of The SwissKASH system we developed in this study relies on tagging zDHHCs at their Cterminus with the KASH domain of syne-1/nesprin-1 for the ectopic ONM targeting. We applied this strategy only to PM-and Golgi-localized zDHHCs but we expect it will also work for the remaining PATs, excluding zDHHC24 with a predicted C-terminus facing the lumen 38 .

Some of the ER-localized zDHHCs, however, showed a prominent ONM localization that might hinder their usage in the SwissKASH system. In this case, alternative tags for the targeting of ER-localized zDHHCs to the PM, Golgi or mitochondria might be developed. The

(palmitoyltransferase conserved C-terminus) motifs that seem relevant for the overall protein structure 56 . The extreme C-terminal region of zDHHCs appears unstructured and is most likely not involved in the binding and presentation of substrates 11 , implying that the fusion of a KASH domain does not interfere with substrate specificity. Accordingly, our SwissKASH pointed to zDHHC3, 7, and 11 as the major PATs for Gαo. This result agrees with a previous study showing zDHHC3 and 7 as the main PATs for Gαi2, Gαq and Gαs 57 , while zDHHC11 activity toward Gα subunits has not been detected. This discrepancy could be explained by a differential turnover rate of PM-and Golgi-localized Gα subunits. For instance, if the turnover of the PM pool of Gαi2 is much faster than its Golgi pool, the S-palmitoylation of Gαi2 by the PM-localized zDHHC11 might have gone unnoticed by the biochemical methods used in that study. The SwissKASH system might therefore provide an advantage in sensitivity by targeting zDHHCs to the ONM, as even small amounts of a substrate are visible at this ectopic compartment. In agreement with that, we found that in our SwissKASH assay Gαi2 is recruited to the ONM by zDHHC11 as well as Gαo is (data not shown).

Several recent studies have revealed that various zDHHCs are regulated by accessory proteins which control their activity, stability and/or localization 43 . We focused here on GCP16/Golga7 and Golga7b, and introduced them into the SwissKASH approach. We found that the zDHHC5-Golga7b complex efficiently targeted MGNC-Nt 7 to the ONM, an effect not observed for Gαo-Nt 7 or in the absence of Golga7b. Interestingly, our MGNC-Nt 7 construct resembles the N-terminus of flotillin-2 (also known as reggie-1) that is myristoylated at Gly2 and palmitoylated at Cys4 by zDHHC5 42 , and it is similarly localized at the PM but excluded from Golgi 58 . These data indicate that the position of the palmitoylatable Cys within a myristoylated Nt 7 peptide might be relevant for substrate specificity by zDHHC5. In the SwissKASH assay, zDHHC5 efficiently targeted both GCP16/Golga7 and Golga7b to the ONM although only the zDHHC5-Golga7b complex co-recruited MGNC-Nt 7 , pointing to striking different functions for these complexes. Thus, the SwissKASH system might also be applied for functional studies of the complexes formed by zDHHCs and accessory proteins.

A polybasic stretch present in the N-terminal region of all Gα subunits has been implicated in PM binding 59 . The Gαo-Nt 31 construct containing the basic region within the α -helix showed indeed a greater steady-state localization at the PM compared to Gαo-Nt 7 . In the SwissKASH system, the presence of the α -helix in Gαo-Nt 31 appears to impact substrate recognition by the Golgi-associated zDHHC3 and 7, but not by the PM-localized zDHHC11. Thus, these data point to a second level of complexity in the substrate affinity by zDHHCs, where regions distant from the palmitoylatable Cys might subserve regulatory functions. How the polybasic region in Gαo impacts the substrate specificity by zDHHCs remains to be clarified.

S-palmitoylation has gained much attention lately as a potential target for drug discovery to combat pathologies mediated by proteins such as the oncogenic Ras and infectious diseases like malaria caused by Plasmodium falciparum or the respiratory syndromes caused by coronaviruses 60-62 . Our SwissKASH system could enable screens for molecules that perturb site-and zDHHC-specific S-palmitoylation of pathological proteins. This approach may provide an attractive alternative to directly target the desired oncogene (or protein of another pathogenic activity), focusing instead on developing tools to target the zDHHCs controlling the proper (or pathological) localization of the protein. In this regard, zDHHCs can be targeted by the drug discovery efforts. The large number of these enzymes in humans and their distinct expression patterns provide the reasoning to expect the power of such an approach in obtaining the favorable pharmacodynamics with limited side effects. Another approach might aim at targeting the specific zDHHC-substrate interaction pairs; this avenue is expected to deliver even more specific targeted therapies.

To sum up, we have delineated the code describing the Golgi vs. PM localization of the G protein Gαo, showed that these two localizations are independent from the previously assumed Golgi-to-PM trafficking, and discovered a general mechanism controlling PMP localization to its target membrane through the substrate selectivity of differently localized

PATs. This major insight into the cell biology of protein subcellular localization may pave the way to novel drug discovery principles.

Monoclonal antibodies (mAbs) against flotillin-2 (Cat# 610383) and GM130 (Cat# 610823) were from BD Biosciences, mAb against HA-tag (Cat# 11867423001) from Roche, mAb against mRFP (Cat# sc-101526) from Santa Cruz Biotechnology, mAb against His 6 (Cat# 34650) from Qiagen, mAb against GAPDH (Cat# GTX28245) and polyclonal antibody (pAb) against GFP (Cat# GTX113617) were from GeneTex, mAb against α -tubulin (Cat# T6199) and pAb against Flag-tag (Cat# F7425) were from Sigma-Aldrich, and a pAb against GFP 

The plasmids Gαo-GFP WT and Q205L mutant, GalT-GFP, His 6 -RGS19, and GalT-mRFP for Drosophila expression were previously described 5, 48 . To generate the GFP-fusion of Gαo-Nt 7 and Gαo-Nt 31 , the fragments were PCR-amplified (primers listed in Supplementary Table   3 ) from Gαo-GFP, products were cut with KpnI/AgeI and cloned in frame into the same sites of pEGFP-N1 (Clontech). The Gαo-Nt 8-31 -GFP sequence was PCR-amplified from Gαo-Nt 31 -GFP, the product cut with KpnI/NotI and used to replace the GFP sequence in pEGFP-N1 cut with the same enzymes. Gαo-Nt 7 -GFP was used as template for the PCR amplification of Coverslips were finally mounted with Vectashield on microscope slides. Cells were recorded with a Plan-Apochromat 63x/1.4 oil objective on a LSM800 Confocal Microscope and further processed using the ZEN blue software (all Zeiss). When required, mean fluorescence intensity was determined from confocal images using ImageJ (National Institutes of Health). 1 Images were not recorded using the same confocal settings, therefore ratio fluorescence values, such as Golgi fluorescence vs. total fluorescence or PM vs. total, were used for quantifications (see below). As a proof of validity of this approach, we recorded >50 cells expressing the GFP constructs under identical confocal settings, finding that the Golgi signal from Gαo-Nt 7 -GFP is ca. 1.5-fold higher, and its PM signal is ca. 2-fold lower, than those of Gαo-Nt 31 -GFP (data not shown), recapitulating the ratio representation we adopted in Fig.   1e ,f and further elsewhere.

N2a cells expressing the GFP-fusion constructs were immunostained as indicated above using a mouse monoclonal antibody (mAb) against GM130 to visualize the Golgi apparatus, and a DAPI staining for the nucleus (both not shown in all final images). Alternatively, coexpression of the MannII-BFP construct was used to label the Golgi (see below under "colocalization analysis" for plasmid ratio used for transfection). To avoid interferences due to different expression levels of GFP-constructs among cell population, mean fluorescence intensity was measured at the GM130-or MannII-BFP-positive Golgi region as well as at the total cell area, and ratio values were used to determine the relative Golgi accumulation of the constructs. Simultaneously, mean fluorescence intensity was determined at an unbroken region of the PM lacking membrane protrusions, and the ratio over total cell fluorescence was used to define relative PM content for each GFP-construct. One-way ANOVA or Student's t-test were used for statistical analysis of ≥ 50 cells per condition and from at least 3 independent experiments.

N2a cells were transfected and immunostained against GM130 as described above. To determine co-localization of the various GFP constructs and the GM130 signal, an area covering the whole perinuclear region but excluding the PM was selected in confocal images and the Pearson's correlation was calculated using the co-localization tool of ImageJ. The same analysis was done in N2a cells co-expressing the phosphatidylserine biosensor mRFP-Lact-C2 25 and the different GFP-fusions, transfected at equal plasmid ratio. The Golgi marker

GalT-GFP was used as control. This analysis was also done in N2a cells co-transfected with GFP-fusions, HA-tagged zDHHCs or empty pcDNA3.1(+), and MannII-BFP as the Golgi marker (2:4:1 plasmid ratio). One-way ANOVA test was used for statistical analysis of >30 cells per condition. 

Transfected N2a cells were lysed with ice-cold Lysis buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl 2 , 2 mM EDTA, 1% Triton X-100, 0.1% SDS, and 10% glycerol) supplemented with a protease inhibitor cocktail (Roche). Extracts were cleared by centrifugation at 15,000xg and 4°C, boiled at 95°C for 5 min and finally analyzed by SDS-PAGE and Western blots using antibodies against GFP, α -tubulin as loading control, and HAtag when required. HRP-conjugated secondary antibodies were used for enhanced chemiluminescence (ECL) detection. Quantification of blots was done using ImageJ from at least 3 independent experiments and statistical analysis was carried out using Student's ttest.

The recombinant GST-tagged Nanobody against GFP 70 

Rosettagami (Novagen) was purified with glutathione Sepharose 4B beads according to manufacturer's instructions. Protein purity was assessed by SDS-PAGE and Coomassie blue staining.

N2a cells were co-transfected with the different Gαo-GFP constructs and mRFP-Gβ1/Gγ3 at 1:1:1 plasmid ratio. HeLa cells were transfected with the constructs used for the SwissKASH assay at the same plasmid ratio described below. SUN2-GFP was used as positive control for the interaction with mRFP-zDHHC-KASH constructs. After 24 hr transfection, cells were resuspended with ice-cold GST-lysis buffer (20 mM Tris-HCl, pH 8.0, 1% Triton X-100 and 10% glycerol in PBS) supplemented with a protease inhibitor cocktail (Roche) and 50 µM Palmostatin B (for SwissKASH-derived samples), and passed 10 times through a 25G needle. Extracts were cleared by centrifugation at 15,000xg for 15 min at 4°C, and supernatants were incubated with 2 µg of purified GST-tagged GFP-Nanobody for 30 min on ice. Then, 20 µL of Glutathione Sepharose 4B beads were added and samples rotated overnight at 4°C. Beads were repeatedly washed with GST-lysis buffer, prepared for SDS-PAGE, and finally analyzed by Western blot using antibodies against GFP, mRFP, and Flagtag when needed, as well as HRP-conjugated secondary antibodies for ECL detection. All co-immunoprecipitations were done in duplicate with very similar outcomes.

N2a cells were transfected for 24 hr and cell extracts were prepared using non-denaturing conditions and fractionated by high-speed centrifugation as previously described 68 . Briefly, cells were rinsed twice with PBS and resuspended in hypo-osmotic buffer (20 mM HEPES, pH 7.0) supplemented with a protease inhibitor cocktail. The cell suspension was passed 20 times through a 25G needle, and nuclei and unbroken cells were removed by centrifugation at 700xg for 10 min at 4°C. The supernatant was centrifuged at 100,000xg for 60 min at 4°C.

The new supernatant (cytosolic fraction) was directly prepared for SDS-PAGE, and the pellet (membrane fraction) was gently washed with hypo-osmotic buffer and resuspended in GSTlysis buffer supplemented with 0.5% SDS and protease inhibitors. The membrane fraction was cleared by centrifugation at 15,000xg for 20 min at 4°C, and prepared for SDS-PAGE.

Western blot analysis was done as above using the antibodies against GFP, and flotillin-2 and GAPDH as endogenous membrane and cytosolic markers, respectively. Two-way ANOVA was used for statistical analysis of 4-6 independent experiments. S-palmitoylation at the outer nuclear membrane (SwissKASH assay) HeLa cells were co-transfected as above with plasmids encoding the GFP-fusion, SUN2, and control mRFP/BFP-KASH or mRFP/BFP-zDHHC-KASH at a 1:3:3 plasmid ratio, at a 1:2:2:1 when GCP16/Golga7-Flag, Golga7b-Flag or His 6 -RGS19 was included, or at 1:2:2:1:1 when mRFP-Gβ1 and mRFP-Gγ3 were co-transfected. Cells were then seeded on poly-L-lysinecoated coverslips, fixed and prepared for microscopy. For quantification, mean GFPfluorescence intensity at the ONM region labelled by the mRFP-KASH fusion was determined using ImageJ. Simultaneously, GFP-fluorescence was measured at a nearby cytosolic region as well, and the ratio ONM over cytosol was used to define the relative ONM content of each GFP-construct. Ratio values were used due to different expression levels of the GFP-constructs among the cell population. One-way ANOVA or Student's t-test were used for statistical analysis of **p≤0.005; ***p≤0.001; ****p≤0.0001 using one-way or two-way ANOVA with Tukey's post hoc test (for multi-sample groups), and two-sided unpaired Student's t-test or Mann-Whitney U test (for two-sample comparison). GraphPad Prism 9 was used to determine statistical significance. No statistical methods were used to predetermine the sample sizes. All replicates successfully reproduced the presented findings.

The data that support the findings of this study are available from the corresponding authors upon reasonable request. Source data are provided with this paper. Gao-S6A-Nt -GFP 7 Gao-S6C-Nt -GFP 7 Gao-S6G-Nt -GFP 7 Gao-S6T-Nt -GFP Gao-GFP Gao-GFP GM130 7 Gao-Nt -GFP 7 Gao-Nt -GFP GM130 31 Gao-Nt -GFP 31 Gao-Nt -GFP GM130 7 Gao-C3N-Nt -GFP GM130 MGNC-Nt -GFP mRFP-zDHHS5-KASH Golga7b-Flag 31 Gao-Nt -GFP 31 Gao-Nt -GFP mRFP-KASH 31 Gao-Nt -GFP 31 Gao-Nt -GFP mRFP-zDHHC3-KASH 31 Gao-Nt -GFP 31 Gao-Nt -GFP mRFP-zDHHC7-KASH 31 Gao-Nt -GFP 31 Gao-Nt -GFP mRFP-zDHHC11-KASH 

Trends in GPCR drug discovery: new agents, targets and indications

Heterotrimeric G protein activation by G-proteincoupled receptors

When trafficking and signaling mix: How subcellular location shapes G protein-coupled receptor activation of heterotrimeric G proteins

Signaling at the Golgi: sensing and controlling the membrane fluxes

Golgi-Resident Galphao Promotes Protrusive Membrane Dynamics

Regulation of G proteins by covalent modification

The biology and enzymology of protein Nmyristoylation

New insights into the mechanisms of protein palmitoylation

N-myristoylation: from cell biology to translational medicine

Structure and function of DHHC protein Sacyltransferases

The molecular mechanism of DHHC protein acyltransferases

The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins

Postsynaptic nanodomains generated by local palmitoylation cycles

Spatial organization of palmitoyl acyl transferases governs substrate localization and function

G-protein alpha-subunit expression, myristoylation, and membrane association in COS cells

A novel Nterminal motif for palmitoylation of G-protein alpha subunits

The palmitoylation status of the G-protein G(o)1 alpha regulates its activity of interaction with the plasma membrane

Structural and genomic decoding of human and plant myristoylomes reveals a definitive recognition pattern

The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2

Regulation of G Protein betagamma Signaling

GPS-Lipid: a robust tool for the prediction of multiple lipid modification sites

Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases

Trafficking and signaling by fatty-acylated and prenylated proteins

Extent of N-terminal modifications in cytosolic proteins from eukaryotes

Membrane phosphatidylserine regulates surface charge and protein localization

Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M

Regulation of protein secretion through controlled aggregation in the endoplasmic reticulum

Reduced temperature prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal glycosylation

A targeted siRNA screen to identify SNAREs required for constitutive secretion in mammalian cells

Understanding the diversity of membrane lipid composition

Substrate selectivity in the zDHHC family of S-acyltransferases

Protein lipid overlay assay

A plasma membrane pool of phosphatidylinositol 4-phosphate is generated by phosphatidylinositol 4-kinase type-III alpha: studies with the PH domains of the oxysterol binding protein and FAPP1

Intracellular localization and tissuespecific distribution of human and yeast DHHC cysteine-rich domain-containing proteins

S-Palmitoylation Sorts Membrane Cargo for Anterograde Transport in the Golgi

Identification of PSD-95 palmitoylating enzymes

Local palmitoylation cycles define activity-regulated postsynaptic subdomains

The molecular era of protein S-acylation: spotlight on structure, mechanisms, and dynamics

Structural insights into LINC complexes

Identification of a Novel Sequence Motif Recognized by the Ankyrin Repeat Domain of zDHHC17/13 S-Acyltransferases

Palmitoylation of caveolin-1 is regulated by the same DHHC acyltransferases that modify steroid hormone receptors

DHHC5 protein palmitoylates flotillin-2 and is rapidly degraded on induction of neuronal differentiation in cultured cells

Accessory proteins of the zDHHC family of S-acylation enzymes

A ZDHHC5-GOLGA7 Protein Acyltransferase Complex Promotes Nonapoptotic Cell Death

DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H-and N-Ras

S-acylated Golga7b stabilises DHHC5 at the plasma membrane to regulate cell adhesion

Palmitoylated calnexin is a key component of the ribosometranslocon complex

Double suppression of the Galpha protein activity by RGS proteins

A heterotrimeric G protein, G alpha i-3, on Golgi membranes regulates the secretion of a heparan sulfate proteoglycan in LLC-PK1 epithelial cells

Palmitoylated acyl protein thioesterase APT2 deforms membranes to extract substrate acyl chains

Acylation -A New Means to Control Traffic Through the Golgi

Stochastic palmitoylation of accessible cysteines in membrane proteins revealed by native mass spectrometry

The Drosophila protein palmitoylome: characterizing palmitoylthioesterases and DHHC palmitoyl-transferases

Regulation and function of the palmitoylacyltransferase ZDHHC5

Fatty acyl recognition and transfer by an integral membrane Sacyltransferase

Identification of G protein alpha subunit-palmitoylating enzyme

Reggies/flotillins interact with Rab11a and SNX4 at the tubulovesicular recycling compartment and function in transferrin receptor and Ecadherin trafficking

Structural homology discloses a bifunctional structural motif at the N-termini of G alpha proteins

Protein Lipidation in Cell Signaling and Diseases: Function, Regulation, and Therapeutic Opportunities

Post-translational modifications of coronavirus proteins: roles and function

Protein palmitoylation and cancer

Quantitative multiphoton spectral imaging and its use for measuring resonance energy transfer

An enhanced monomeric blue fluorescent protein with the high chemical stability of the chromophore

Nuclear alignment in myotubes requires centrosome proteins recruited by nesprin-1

SUN proteins facilitate the removal of membranes from chromatin during nuclear envelope breakdown

Systematic siRNA Screen Unmasks NSCLC Growth Dependence by Palmitoyltransferase DHHC5

Reggie/flotillin proteins are organized into stable tetramers in membrane microdomains

The Q-soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (Q-SNARE) SNAP-47 Regulates Trafficking of Selected Vesicle-associated Membrane Proteins (VAMPs)

Architectures of multisubunit complexes revealed by a visible immunoprecipitation assay using fluorescent fusion proteins

Quantification of mean fluorescence intensity ratios of GFP-fusions at the ONM versus cytosol (e). Box plots indicate median (middle line), 25th, 75th percentile (box), and lowest, highest value (whiskers) from 3 independent experiments (Gαo-Nt 7 and mRFP-KASH, n=44; Gαo-Nt 7 and zDHHC11, n=45; MGNTC-Nt 7 and mRFP-KASH, n=49; MGNTC-Nt 7 and zDHHC11, n=43). h-m

MGNC-Nt 7 -GFP poorly localizes at the ONM in the presence of mRFP-zDHHC3-KASH (h) and mRFP-zDHHC7-KASH (i). DAPI stained nuclei in blue and selected areas are magnified to the right. Quantification of mean fluorescence intensity ratios of GFP-fusions at the ONM versus cytosol by zDHHC3 (j) and zDHHC7 (k)

Box plots indicate median (middle line), 25th, 75th percentile (box), and lowest, highest value (whiskers) from 3 independent experiments (Gαo-Nt 7 and mRFP-KASH, n=44; Gαo-Nt 7 and zDHHC3, n=50; Gαo-Nt 7 and zDHHC7, n=46

MGNTC-Nt 7 and zDHHC3, n=53; MGNTC-Nt 7 and zDHHC7, n=45). l-o, ONM recruitment of

7 -GFP is not observed in the SwissKASH assay using the inactive DHHS-mutants for zDHHC3 (zDHHS3; l), zDHHC7 (zDHHS7; m), and zDHHC11 (zDHHS11; n). The zDHHS11 MGNC-Nt -GFP GM130

GFP mRFP-zDHHC7-KASH Gao-GFP Gao-GFP mRFP-zDHHC11-KASH Gao-GFP mRFP-Gb1g3 Gao-Q205L-GFP His-RGS19

GFP mRFP-zDHHC5-KASH Golga7b-Flag Gao-GFP mRFP-zDHHC5-KASH Golga7b-Flag

The work was supported with the Swiss National Science Foundation grants 31003A_175658 to V.L.K and 310030_192608 to F.G.V.D.G. We would like to thank Sabina Troccaz for the excellent technical assistance and members of the Bioimaging core facility of the CMU for assistance in microscopy. 

The authors declare no competing interests.